Chronic Obstructive Pulmonary Disease (COPD)
Chronic obstructive pulmonary disease (COPD) is a chronic disease of the lungs that involves airway damage and blockage that worsens over time. The progressively worsening airway blockage causes the main symptoms of COPD: difficulty breathing, cough, and mucus production. While the most common cause of COPD is smoking, other causes can include significant exposure to air pollutants, frequent respiratory infections, and untreated asthma. Standard COPD treatments include use of specific inhalers to relax and open up the airways.
Chronic Obstructive Pulmonary Disease (COPD) falls under theLungs & Breathingcategory.
Last Updated:January 22, 2025
Chronic obstructive pulmonary disease (COPD) is a chronic condition characterized by irreversible lung damage, which leads to symptoms like difficulty breathing and cough. It typically involves both emphysema, in which air sacs in the lungd lose elasticity, and chronic bronchitis, which is marked by airway inflammation and increased mucus production.
The main signs and symptoms of chronic obstructive pulmonary disease (COPD) include shortness of breath, wheezing, chronic cough with mucus, and fatigue and potential additional symptoms such as frequent infections, a blue tint to lips or fingernails, unintentional weight loss, muscle weakness, osteoporosis, and increased cardiovascular disease risk. The severity of the disease influences the variation in symptoms experienced by different people.
Chronic obstructive pulmonary disease (COPD) is diagnosed when a person exhibits long-term breathing difficulties and cough, particularly if they have risk factors like smoking or pollution exposure. Healthcare providers use a combination of signs, symptoms, medical histories, and various tests to confirm the diagnosis.
The main treatments for chronic obstructive pulmonary disease (COPD) include quitting smoking and using inhalers (specifically bronchodilators) to manage symptoms and prevent exacerbations. The choice and frequency of inhaler use depend on the person's symptom severity and exacerbation history.
Few supplements have been studied for chronic obstructive pulmonary disease (COPD), and there is no strong evidence to support their effectiveness. Some examples of these supplements include beetroot juice, chlorella, honey, and black seed oil.
A diet with antioxidant-rich fruits and vegetables may lower the risk of developing chronic obstructive pulmonary disease (COPD), but its effectiveness in managing symptoms is uncertain. Maintaining a healthy diet is crucial for people with COPD because malnutrition can lead to worsened outcomes that include muscle wasting and reduced quality of life.
Exercise is recommended to help manage symptoms and progression of chronic obstructive pulmonary disease (COPD), with an emphasis on maintaining a regular exercise program rather than a specific type of exercise.
Chronic obstructive pulmonary disease (COPD) is primarily caused by long-term exposure to lung irritants, and cigarette smoke is the leading cause in the U.S. Other contributing factors include inhaling various types of smoke, pollution, chemical fumes, and a genetic condition known as alpha-1 antitrypsin deficiency.
- ^Shari Gentry, Barry GentryChronic Obstructive Pulmonary Disease: Diagnosis and ManagementAm Fam Physician.(2017 Apr 1)
- ^The content of this page was partially adapted from MedlinePlus of the National Library of Medicine
- ^Agusti A, Soriano JBCOPD as a systemic disease.COPD.(2008-Apr)
- ^Einar Furulund, Mitra Bemanian, Nina Berggren, Tesfaye Madebo, Sara Hydle Rivedal, Torgeir Gilje Lid, Lars Thore FadnesEffects of Nutritional Interventions in Individuals with Chronic Obstructive Lung Disease: A Systematic Review of Randomized Controlled TrialsInt J Chron Obstruct Pulmon Dis.(2021 Nov 17)
- ^Bernard McCarthy, Dympna Casey, Declan Devane, Kathy Murphy, Edel Murphy, Yves LacassePulmonary rehabilitation for chronic obstructive pulmonary diseaseCochrane Database Syst Rev.(2015 Feb 23)
- ^Renae J McNamara, Zoe J McKeough, David K McKenzie, Jennifer A AlisonWater-based exercise training for chronic obstructive pulmonary diseaseCochrane Database Syst Rev.(2013 Dec 18)
- ^
- ^Sullivan J, Pravosud V, Mannino DM, Siegel K, Choate R, Sullivan TNational and State Estimates of COPD Morbidity and Mortality - United States, 2014-2015.Chronic Obstr Pulm Dis.(2018-Oct-12)
- ^Pavitt MJ, Tanner RJ, Lewis A, Buttery S, Mehta B, Jefford H, Curtis KJ, Banya WAS, Husain S, Satkunam K, Shrikrishna D, Man W, Polkey MI, Hopkinson NSOral nitrate supplementation to enhance pulmonary rehabilitation in COPD: ON-EPIC a multicentre, double-blind, placebo-controlled, randomised parallel group study.Thorax.(2020-07)
- ^Kerley CP, James PE, McGowan A, Faul J, Cormican LDietary nitrate improved exercise capacity in COPD but not blood pressure or pulmonary function: a 2 week, double-blind randomised, placebo-controlled crossover trial.Int J Food Sci Nutr.(2019-Mar)
- ^Al-Azzawi MA, AboZaid MMN, Ibrahem RAL, Sakr MATherapeutic effects of black seed oil supplementation on chronic obstructive pulmonary disease patients: A randomized controlled double blind clinical trial.Heliyon.(2020-Aug)
- ^Keranis E, Makris D, Rodopoulou P, Martinou H, Papamakarios G, Daniil Z, Zintzaras E, Gourgoulianis KIImpact of dietary shift to higher-antioxidant foods in COPD: a randomised trial.Eur Respir J.(2010-Oct)
- ^Baldrick FR, Elborn JS, Woodside JV, Treacy K, Bradley JM, Patterson CC, Schock BC, Ennis M, Young IS, McKinley MCEffect of fruit and vegetable intake on oxidative stress and inflammation in COPD: a randomised controlled trial.Eur Respir J.(2012-Jun)
- ^Sugawara K, Takahashi H, Kashiwagura T, Yamada K, Yanagida S, Homma M, Dairiki K, Sasaki H, Kawagoshi A, Satake M, Shioya TEffect of anti-inflammatory supplementation with whey peptide and exercise therapy in patients with COPD.Respir Med.(2012-Nov)
- ^Ahnfeldt-Mollerup P, Hey H, Johansen C, Kristensen S, Brix Lindskov J, Jensahnfeldt-Mollerupen CThe effect of protein supplementation on quality of life, physical function, and muscle strength in patients with chronic obstructive pulmonary disease.Eur J Phys Rehabil Med.(2015-Aug)
- ^Constantin D, Menon MK, Houchen-Wolloff L, Morgan MD, Singh SJ, Greenhaff P, Steiner MCSkeletal muscle molecular responses to resistance training and dietary supplementation in COPD.Thorax.(2013-Jul)
- ^Salvi SS, Barnes PJChronic obstructive pulmonary disease in non-smokers.Lancet.(2009-Aug-29)
- Weight - Fuld JP, Kilduff LP, Neder JA, Pitsiladis Y, Lean ME, Ward SA, Cotton MMCreatine supplementation during pulmonary rehabilitation in chronic obstructive pulmonary diseaseThorax.(2005 Jul)
- Weight - Deacon SJ, Vincent EE, Greenhaff PL, Fox J, Steiner MC, Singh SJ, Morgan MDRandomized controlled trial of dietary creatine as an adjunct therapy to physical training in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med.(2008 Aug 1)
- COPD Symptoms - Faager G, Söderlund K, Sköld CM, Rundgren S, Tollbäck A, Jakobsson PCreatine supplementation and physical training in patients with COPD: a double blind, placebo-controlled studyInt J Chron Obstruct Pulmon Dis.(2006)
- Exercise Capacity (with Heart Conditions) - Al-Ghimlas F, Todd DCCreatine supplementation for patients with COPD receiving pulmonary rehabilitation: a systematic review and meta-analysisRespirology.(2010 Jul)
- Weight - Funamoto M, Sunagawa Y, Katanasaka Y, Miyazaki Y, Imaizumi A, Kakeya H, Yamakage H, Satoh-Asahara N, Komiyama M, Wada H, Hasegawa K, Morimoto THighly absorptive curcumin reduces serum atherosclerotic low-density lipoprotein levels in patients with mild COPDInt J Chron Obstruct Pulmon Dis.(2016 Aug 26)
- Weight - A Borghi-Silva, V Baldissera, L M M Sampaio, V A Pires-DiLorenzo, M Jamami, A Demonte, J S Marchini, D CostaL-carnitine as an ergogenic aid for patients with chronic obstructive pulmonary disease submitted to whole-body and respiratory muscle training programsBraz J Med Biol Res.(2006 Apr)
- COPD Symptoms - Decramer M, Rutten-van Mölken M, Dekhuijzen PN, Troosters T, van Herwaarden C, Pellegrino R, van Schayck CP, Olivieri D, Del Donno M, De Backer W, Lankhorst I, Ardia AEffects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trialLancet.(2005 Apr 30-May 6)
- COPD Symptoms - De Benedetto F, Aceto A, Dragani B, Spacone A, Formisano S, Pela R, Donner CF, Sanguinetti CMLong-term oral n-acetylcysteine reduces exhaled hydrogen peroxide in stable COPDPulm Pharmacol Ther.(2005)
- COPD Symptoms - Peter N Black, Althea Morgan-Day, Tracey E McMillan, Phillippa J Poole and Robert P YoungRandomised, controlled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary diseasePulmonary Medicine.()
- COPD Symptoms - Jiang C, Zou J, Lv Q, Yang YSystematic review and meta-analysis of the efficacy of N-acetylcysteine in the treatment of acute exacerbation of chronic obstructive pulmonary disease.Ann Palliat Med.(2021-Jun)
- COPD Symptoms - Huang C, Kuo S, Lin L, Yang YThe efficacy of -acetylcysteine in chronic obstructive pulmonary disease patients: a meta-analysis.Ther Adv Respir Dis.(2023)
- Neutrophil Activity - van Overveld FJ, Vermeire PA, De Backer WAInduced sputum of patients with chronic obstructive pulmonary disease (COPD) contains adhesion-promoting, therapy-sensitive factorsInflamm Res.(2000 Jan)
- Bronchitis Symptoms - Wei J, Pang CS, Han J, Yan HEffect of Orally Administered N-Acetylcysteine on Chronic Bronchitis: A Meta-analysis.Adv Ther.(2019-Dec)
- COPD Symptoms - Liang R, Liu D, Li H, Yan Y, Xie W, Zhai ZThe efficacy and safety of herbal formulas for adults with pulmonary hypertension combined with chronic obstructive pulmonary disease: a systematic review and meta-analysis involving 1,865 participants.J Thorac Dis.(2024 Sep 30)
- Blood Pressure - Alshafie S, El-Helw GO, Fayoud AM, Elrashedy AA, Gbreel MI, Alfayoumi SS, Mohamed IM, Abdelwadoud GT, Isa AS, Ragab KM, Nourelden AZEfficacy of dietary nitrate-rich beetroot juice supplementation in patients with chronic obstructive pulmonary disease (COPD): A systematic review and meta-analysis.Clin Nutr ESPEN.(2021 Apr)
- Blood Pressure - Yang H, He S, Chen F, Liang L, Pan JEfficacy and safety of nitrate supplementation on exercise tolerance in chronic obstructive pulmonary disease: A systematic review and meta-analysis.Medicine (Baltimore).(2022 Jan 14)
- Exercise Capacity - Wang J, Feng F, Zhao Y, Bai L, Xu Y, Wei Y, He H, Zhou XDietary nitrate supplementation to enhance exercise capacity in patients with COPD: Evidence from a meta-analysis of randomized controlled trials and a network pharmacological analysis.Respir Med.(2024-Feb)
- Vascular Function - Delacoste FBC, Goulart CDL, Guidoti AB, Türck P, Eibel B, Irigoyen MC, de Araujo CLP, Dal Lago PEvaluating the impact of short-term nitrate-rich dietary supplementation on endothelial function in COPD: A randomized crossover study.Respir Med.(2024 Oct)
- Uric Acid - Abdollahi S, Vajdi M, Meshkini F, Vasmehjani AA, Sangsefidi ZS, Clark CCT, Soltani SResveratrol may mildly improve renal function in the general adult population: A systematic review and meta-analysis of randomized controlled clinical trials.Nutr Res.(2023-May)
- C-Reactive Protein (CRP) - Armita Mahdavi Gorabi, Saeed Aslani, Danyal Imani, Bahman Razi, Thozhukat Sathyapalan, Amirhossein SahebkarEffect of resveratrol on C-reactive protein: An updated meta-analysis of randomized controlled trialsPhytother Res.(2021 Dec)
- Exercise Capacity (with Heart Conditions) - Marwood S, Jack S, Patel M, Walker P, Bowtell J, Calverley PNo effect of glutamine ingestion on indices of oxidative metabolism in stable COPDRespir Physiol Neurobiol.(2011 Jun 30)
- Lung Function - Pletcher MJ, Vittinghoff E, Kalhan R, Richman J, Safford M, Sidney S, Lin F, Kertesz SAssociation between marijuana exposure and pulmonary function over 20 yearsJAMA.(2012 Jan 11)
- Lung Function - Yu H, Lei T, Su X, Zhang L, Feng Z, Dong M, Hou Z, Guo H, Liu JEfficacy and safety of three species of L. in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis.Front Pharmacol.(2023)
- C-Reactive Protein (CRP) - Yu H, Su X, Lei T, Zhang C, Zhang M, Wang Y, Zhu L, Liu JEffect of Omega-3 Fatty Acids on Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Int J Chron Obstruct Pulmon Dis.(2021 Sep 23)
- Exercise Tolerance - Kikuchi H, Shiozawa N, Takata S, Ashida K, Mitsunobu FEffect of repeated Waon therapy on exercise tolerance and pulmonary function in patients with chronic obstructive pulmonary disease: a pilot controlled clinical trial.Int J Chron Obstruct Pulmon Dis.(2014)
- Cathelicidin - Sanders EC, Burkes RM, Mock JR, Brown TT, Wise RA, Hansel NN, Liu MC, Drummond MBBronchoalveolar Lavage and Plasma Cathelicidin Response to 25-Hydroxy Vitamin D Supplementation: A Pilot Study.Chronic Obstr Pulm Dis.(2021-Jul-28)
- Interleukin 8 - Norheim KL, Ben Ezra M, Heckenbach I, Andreasson LM, Eriksen LL, Dyhre-Petersen N, Damgaard MV, Berglind M, Pricolo L, Sampson D, Dellinger RW, Sverrild A, Treebak JT, Ditlev SB, Porsbjerg C, Scheibye-Knudsen MEffect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial.Nat Aging.(2024 Dec)